Continuous venovenous hemofiltration: effects on monocyte and lymphocyte immunophenotype in critically ill patients

Int J Artif Organs. 2002 Nov;25(11):1066-73. doi: 10.1177/039139880202501105.

Abstract

The aim of this study was to test the hypothesis that continuous venovenous hemofiltration (CVVH) increases HLA-DR expression on monocytes and T lymphocytes in critically ill patients. 24 septic (SP) and 10 non-septic (NSP) medical ICU patients with acute renal failure were studied prospectively. The ultrafiltration rate was 20-30 ml.kg(-1).h(-1). The total and differential white cell counts were measured and CD3+ lymphocyte count, HLA-DR expression on CD14+ monocytes and CD3+ lymphocytes were analysed by two-colour flow cytometry before, 4 and 24 h after CVVH initiation, respectively. CVVH did not influence leukocyte, granulocyte, total lymphocyte and CD3+ lymphocyte counts in both groups of patients. The percentage of HLA-DR+/CD14+ monocytes in SP revealed no changes, whereas it decreased after 4 h of CWH in NSP (p < 0.05). The percentage of HLA-DR+/CD3+ lymphocytes in SP decreased after 24 h (p < 0.05), whereas it remained unchanged in NSP. We conclude that CWH initiation is not associated with the increase of HLA-DR expression on CD14+ monocytes and T lymphocytes in critically ill patients with acute renal failure.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • APACHE
  • Acute Kidney Injury / immunology*
  • Acute Kidney Injury / mortality
  • Acute Kidney Injury / therapy*
  • Adult
  • Aged
  • CD3 Complex / immunology*
  • Case-Control Studies
  • Critical Illness
  • Female
  • HLA-DR Antigens / immunology*
  • Hemofiltration / methods*
  • Humans
  • Intensive Care Units
  • Lipopolysaccharide Receptors / immunology*
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Monocytes / immunology
  • Probability
  • Prognosis
  • Prospective Studies
  • Reference Values
  • Sensitivity and Specificity
  • Sepsis / immunology
  • Sepsis / mortality
  • Sepsis / therapy
  • Statistics, Nonparametric
  • Survival Rate
  • T-Lymphocytes / immunology
  • Treatment Outcome

Substances

  • CD3 Complex
  • HLA-DR Antigens
  • Lipopolysaccharide Receptors